Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4
- PMID: 14691263
- PMCID: PMC314196
- DOI: 10.1073/pnas.0303329101
Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4
Abstract
TRPV4 is a Ca(2+)- and Mg(2+)-permeable cation channel within the vanilloid receptor subgroup of the transient receptor potential (TRP) family, and it has been implicated in Ca(2+)-dependent signal transduction in several tissues, including brain and vascular endothelium. TRPV4-activating stimuli include osmotic cell swelling, heat, phorbol ester compounds, and 5',6'-epoxyeicosatrienoic acid, a cytochrome p450 epoxygenase metabolite of arachidonic acid (AA). It is presently unknown how these distinct activators converge on opening of the channel. Here, we demonstrate that blockers of phospholipase A(2) (PLA(2)) and cytochrome p450 epoxygenase inhibit activation of TRPV4 by osmotic cell swelling but not by heat and 4alpha-phorbol 12,13-didecanoate. Mutating a tyrosine residue (Tyr-555) in the N-terminal part of the third transmembrane domain to an alanine strongly impairs activation of TRPV4 by 4alpha-phorbol 12,13-didecanoate and heat but has no effect on activation by cell swelling or AA. We conclude that TRPV4-activating stimuli promote channel opening by means of distinct pathways. Cell swelling activates TRPV4 by means of the PLA(2)-dependent formation of AA, and its subsequent metabolization to 5',6'-epoxyeicosatrienoic acid by means of a cytochrome p450 epoxygenase-dependent pathway. Phorbol esters and heat operate by means of a distinct, PLA(2)- and cytochrome p450 epoxygenase-independent pathway, which critically depends on an aromatic residue at the N terminus of the third transmembrane domain.
Figures
Similar articles
-
Determinants of 4 alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4.J Biol Chem. 2007 Apr 27;282(17):12796-803. doi: 10.1074/jbc.M610485200. Epub 2007 Mar 6. J Biol Chem. 2007. PMID: 17341586
-
TRPV4.Handb Exp Pharmacol. 2007;(179):189-205. doi: 10.1007/978-3-540-34891-7_11. Handb Exp Pharmacol. 2007. PMID: 17217058 Review.
-
Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.Circ Res. 2005 Oct 28;97(9):908-15. doi: 10.1161/01.RES.0000187474.47805.30. Epub 2005 Sep 22. Circ Res. 2005. PMID: 16179585
-
TRPV4 calcium entry channel: a paradigm for gating diversity.Am J Physiol Cell Physiol. 2004 Feb;286(2):C195-205. doi: 10.1152/ajpcell.00365.2003. Am J Physiol Cell Physiol. 2004. PMID: 14707014 Review.
-
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.Nature. 2003 Jul 24;424(6947):434-8. doi: 10.1038/nature01807. Nature. 2003. PMID: 12879072
Cited by
-
Targeting TRPV4 Channels for Cancer Pain Relief.Cancers (Basel). 2024 Apr 27;16(9):1703. doi: 10.3390/cancers16091703. Cancers (Basel). 2024. PMID: 38730655 Free PMC article. Review.
-
Recent advances on the structure and the function relationships of the TRPV4 ion channel.Channels (Austin). 2024 Dec;18(1):2313323. doi: 10.1080/19336950.2024.2313323. Epub 2024 Feb 14. Channels (Austin). 2024. PMID: 38354101 Free PMC article. Review.
-
Transcriptomic profile of the mechanosensitive ion channelome in human cardiac fibroblasts.Exp Biol Med (Maywood). 2023 Dec;248(23):2341-2350. doi: 10.1177/15353702231218488. Epub 2023 Dec 30. Exp Biol Med (Maywood). 2023. PMID: 38158807 Free PMC article.
-
The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.Cells. 2023 Dec 1;12(23):2755. doi: 10.3390/cells12232755. Cells. 2023. PMID: 38067183 Free PMC article. Review.
-
TRPV4 enhances the synthesis of fatty acids to drive the progression of ovarian cancer through the calcium-mTORC1/SREBP1 signaling pathway.iScience. 2023 Oct 18;26(11):108226. doi: 10.1016/j.isci.2023.108226. eCollection 2023 Nov 17. iScience. 2023. PMID: 37953947 Free PMC article.
References
-
- Montell, C., Birnbaumer, L., Flockerzi, V., Bindels, R. J., Bruford, E. A., Caterina, M. J., Clapham, D., Harteneck, C., Heller, S., Julius, D., et al. (2002) Mol. Cell 9, 229-231. - PubMed
-
- Clapham, D. E., Runnels, L. W. & Strubing, C. (2001) Nat. Rev. Neurosci. 2, 387-396. - PubMed
-
- Harteneck, C., Plant, T. D. & Schultz, G. (2000) Trends Neurosci. 23, 159-166. - PubMed
-
- Montell, C., Birnbaumer, L. & Flockerzi, V. (2002) Cell 108, 595-598. - PubMed
-
- Watanabe, H., Davis, J. B., Smart, D., Jerman, J. C., Smith, G. D., Hayes, P., Vriens, J., Cairns, W., Wissenbach, U., Prenen, J., et al. (2002) J. Biol. Chem. 277, 13569-13577. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous